RhumbLine Advisers’s ArriVent BioPharma AVBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $739K | Sell |
33,954
-3,189
| -9% | -$69.4K | ﹤0.01% | 2410 |
|
|
2025
Q1 | $687K | Buy |
37,143
+453
| +1% | +$8.38K | ﹤0.01% | 2360 |
|
|
2024
Q4 | $977K | Buy |
36,690
+3,069
| +9% | +$81.8K | ﹤0.01% | 2261 |
|
|
2024
Q3 | $790K | Buy |
33,621
+20,914
| +165% | +$491K | ﹤0.01% | 2395 |
|
|
2024
Q2 | $236K | Buy |
12,707
+2,942
| +30% | +$54.6K | ﹤0.01% | 3137 |
|
|
2024
Q1 | $174K | Buy |
+9,765
| New | +$174K | ﹤0.01% | 3242 |
|